This bill proposes to amend current statutes regarding the dispensing of prescription opioid containers. Specifically, it would eliminate the requirement that the container of a schedule II controlled substance that is an opioid, directly dispensed by a pharmacist and not for immediate use, have a red cap. Instead, the new law would require that such containers have a warning label prescribed by the board about potential addiction. Additionally, the bill makes technical changes to existing language, such as modifying the phrasing around the size of the red "C" stamp on prescriptions and the conditions under which a controlled substance may be dispensed. Furthermore, the bill clarifies that the requirement for a red cap is waived if the board determines that implementing it is not feasible due to specific dosage forms or packaging types. The overall intent of the bill is to streamline the labeling requirements for opioid prescriptions while maintaining necessary warnings about addiction, thereby addressing concerns related to the opioid epidemic without imposing unnecessary burdens on pharmacists.

Statutes affected:
Introduced Version: 36-2525
House Engrossed Version: 36-2525
Chaptered Version: 36-2525